Content Hub

Welcome to the IMPACCT: RWE Content Hub

IMPACCT: Real World Evidence - 2019 Past Presentations Pack

Annotation 2020-08-19 145221

Lessons Learned From The
Development And Implementation of an
Integrated Data And Evidence Strategy
at Abbvie

Tony Hebden PhD
Vice President and Head

Annotation 2020-08-19 150013

The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan

Cathy W Critchlow, PHD
Centre For Observational Research, Amgen, Inc

Annotation 2020-08-19 145943

Use of Real World Data
Outside of Traditional Comparative Effectiveness Research

Ravi Iyer
Director GHEOR
TEVA Pharmaceuticals Inc.

Sandy Leondard Thumb

An interview with Sandy Leonard, former VP, Medical Evidence & Observational Research at AstraZeneca on what the key challenges in implementing a meaningful evidence generation plan are and how RWE approaches can promote patient-facing outcomes in clinical and commercial stages.

IMPACCT: Real World Evidence - 2018 Presentations Pack

Access an exciting compilation of presentations from previous meetings.

This presentation pack contains the following 3 insightful case-studies on the latest uses of RWE across drug life cycle, shared by top experts in the space:

Lundbeck Presentation Thumb

Real World Evidence & Patient Perspective: Opportunities Throughout the Product Lifecycle

A presentation given at IMPACCT: Real World Evidence 2018 by:

Christy Houle PhD, MPH
Director, HEOR

Lou Fiore thumb

Clinical Care & Research Partnership Model to Facilitate Learning & Discovery Through RWE

A presentation given at the 2018 IMPACCT: RWE by:

Lou Fiore MD, MPH
Executive Director - Massachusetts Veterans Epidemiology Research & Information Center
VA Boston Healthcare System

BMS presentation Thumb

Use of RWD to Facilitate the Drug Development Process

A presentation given at the 2018 IMPACCT: RWE by:

Christoph Koenen, MD, MBA
Head of Cardiovascular Development
Therapeutic Area Head
Bristol-Myers Squibb